SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 5.85 |
| Enterprise Value ($M) | 7.89 |
| Book Value ($M) | -2.18 |
| Book Value / Share | -1.10 |
| Price / Book | -2.69 |
| NCAV ($M) | -9.83 |
| NCAV / Share | -4.95 |
| Price / NCAV | -0.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.19 |
| Return on Assets (ROA) | -2.76 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.05 |
| Current Ratio | 1.05 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 10.23 |
| Assets | 10.93 |
| Liabilities | 20.06 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | -47.56 | |
| 13G | Bleichroeder LP | 6.20 | ||
| 13G/A | Nantahala Capital Management, LLC | 1.50 | -98.02 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,123 | 17,024 | 12.47 | |
| 3,029 | 28,426 | 10.66 | |
| 17,675 | 83,234 | 21.24 | |
| 14,213 | 61,536 | 23.10 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ANIX – Anixa Biosciences, Inc. | APM – Aptorum Group Limited |
| APRE – Aprea Therapeutics, Inc. | APVO – Aptevo Therapeutics Inc. |
| ARTL – Artelo Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io